Addressing Confusion about the Risks and Benefits of Co-Testing versus Human Papillomavirus Testing for Cervical Cancer Screening

Acta Cytol. 2017;61(3):252. doi: 10.1159/000472244. Epub 2017 May 5.

Authors

Grace Tan¹, David Hawkes

Affiliation

¹ Victorian Cytology Service, Carlton, VIC, Australia.

PMID: 28472792
DOI: 10.1159/000472244

No abstract available

Publication types

Comparative Study
Letter

MeSH terms

Early Detection of Cancer*
Female
Humans
Papillomaviridae / physiology*
Papillomavirus Infections / diagnosis*
Papillomavirus Infections / pathology
Papillomavirus Infections / virology
Risk Factors
Uterine Cervical Dysplasia / diagnosis
Uterine Cervical Dysplasia / pathology
Uterine Cervical Dysplasia / virology
Uterine Cervical Neoplasms / diagnosis*
Uterine Cervical Neoplasms / pathology
Uterine Cervical Neoplasms / virology